DR. JOHN YIANNI, CEO

PhD in Biophysics, Founder, CEO, Board member of several medical device companies (Biocompatibles, Thermocore, Reverse Medical); launched first coated coronary stent in EU (exit to Abbott); Founder and Board member Reverse medical (exit to Medtronic), Partner, Earlybird Venture Capital Health Fund.

DR. MAURICE BUCHBINDER, CMO

Professor Stanford University, Interventional cardiology KOL and entrepreneur; co-developer of CryoTherapeutics IP and clinical strategy, PI for Corevalve and Stentys clinical trials, Founder M Valve, advisory board of major medtech players.

BERTRAND GRIMMONPRÉ, CFO

Bertrand Grimmonpré is a seasoned finance executive with 20 years of experience General Management & Finance, with an international exposure for private and quoted groups.

Prior to joining Cryotherapeutics as CFO in May 2019, Bertrand has held CFO & VP positions in various Medical Device and Biotech companies like Agentus Therapeutics, Novoste, Volcano Therapeutics, Celyad (Cardio3), Medpole and Miracor Medical. Bertrand has been instrumental in assisting the company to close its latest financing round and to the establishment of the Company in Awans.